Form 8-K - Current report:
SEC Accession No. 0001104659-24-123451
Filing Date
2024-11-27
Accepted
2024-11-27 08:30:46
Documents
21
Period of Report
2024-11-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429573d1_8k.htm   iXBRL 8-K 35970
2 EXHIBIT 1.1 tm2429573d1_ex1-1.htm EX-1.1 245012
3 EXHIBIT 4.1 tm2429573d1_ex4-1.htm EX-4.1 70015
4 EXHIBIT 5.1 tm2429573d1_ex5-1.htm EX-5.1 12800
5 EXHIBIT 99.1 tm2429573d1_ex99-1.htm EX-99.1 9810
6 EXHIBIT 99.2 tm2429573d1_ex99-2.htm EX-99.2 10522
10 GRAPHIC tm2429573d1_ex5-1img001.jpg GRAPHIC 3499
11 GRAPHIC image_002.gif GRAPHIC 351
12 GRAPHIC image_003.gif GRAPHIC 351
  Complete submission text file 0001104659-24-123451.txt   658542

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA repl-20241125.xsd EX-101.SCH 3018
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20241125_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20241125_pre.xml EX-101.PRE 22361
23 EXTRACTED XBRL INSTANCE DOCUMENT tm2429573d1_8k_htm.xml XML 3683
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 241506452
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)